Skip to main content

Table 1 Patients treated with front-line anthracycline + ifosfamide chemotherapy: clinical characteristics and response evaluation

From: Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma

Patients ID Gender Age at time of diagnosis (years) Myxofibrosarcoma grade Site of primary tumour Site of relapse at time of CT Response evaluation criteria in solid tumours (RECIST) evaluation
1 M 53 2 Left thigh Lung PR
2 F 72 2 Right arm Right arm SD
3 M 71 3 Thoracic wall Lung PD
4 F 33 3 Abdomen Lung and abdomen PR
5 F 48 1 Left thigh Left thigh SD
6 F 64 1 Scalp Scalp PR
7 M 55 2 Thoracic wall Lung PD
8 F 44 3 Right thigh Right thigh PD
9 F 51 3 Left thigh Lung SD
10 M 64 2 Abdomen Lung PD
11 M 64 2 Left thigh Lung PD
12 F 33 3 Left thigh Lung and abdomen PD
13 M 48 2 Right thigh Lung PR
  1. M male, F female, CT chemotherapy, PR partial response, SD stable disease, PD progressive disease